Overview
Iomeprol has been investigated for the diagnostic of Coronary Artery Disease.
Indication
用于静脉尿路造影（成人包括肾脏损害或糖尿病患者）、ＣＴ（躯干）、常规血管造影、动脉、心血管造影（成人和儿童）、常规选择性冠状动脉造影、介入性冠状动脉造影、瘘管造影、乳管造影、泪囊造影和涎管造影。
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2010/12/07 | Phase 4 | Completed | |||
2006/10/20 | Phase 4 | Completed | Deutsches Herzzentrum Muenchen | ||
2006/01/23 | Phase 2 | Completed |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| BRACCO DIAGNOSTICS INC | 0270-7300 | INTRAVASCULAR | 612 mg in 1 mL | 7/21/2022 | |
| BIPSO GmbH | 76381-740 | INTRAVASCULAR | 816 mg in 1 mL | 7/21/2022 | |
| BRACCO DIAGNOSTICS INC | 0270-7250 | INTRAVASCULAR | 510 mg in 1 mL | 7/21/2022 | |
| BRACCO DIAGNOSTICS INC | 0270-9350 | INTRAVASCULAR | 714 mg in 1 mL | 7/21/2022 | |
| BIPSO GmbH | 76381-935 | INTRAVASCULAR | 714 mg in 1 mL | 7/21/2022 | |
| BIPSO GmbH | 76381-940 | INTRAVASCULAR | 816 mg in 1 mL | 7/21/2022 | |
| BIPSO GmbH | 76381-735 | INTRAVASCULAR | 714 mg in 1 mL | 7/21/2022 | |
| BRACCO DIAGNOSTICS INC | 0270-7350 | INTRAVASCULAR | 714 mg in 1 mL | 7/21/2022 | |
| BIPSO GmbH | 76381-730 | INTRAVASCULAR | 612 mg in 1 mL | 7/21/2022 | |
| BIPSO GmbH | 76381-725 | INTRAVASCULAR | 510 mg in 1 mL | 7/21/2022 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| IOMERON 400 INJECTION 400 mg/ml | SIN08458P | INJECTION | 400 mg/ml | 11/24/1995 | |
| IOMERON 300 INJECTION 300 mg/ml | SIN08457P | INJECTION | 300 mg/ml | 11/30/1995 | |
| IOMERON 350 INJECTION 350 mg/ml | SIN08462P | INJECTION | 350 mg/ml | 11/30/1995 |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| IOMERON 350 iomeprol 71.44g/100mL injection vial | 63961 | Medicine | A | 5/11/1998 | |
| IOMERON 350 iomeprol 142.88g/200mL injection vial | 63963 | Medicine | A | 5/11/1998 | |
| IOMERON 350 iomeprol 35.72g/50mL injection vial | 63960 | Medicine | A | 5/11/1998 | |
| IOMERON 300 iomeprol 30.62g/50mL injection vial | 63955 | Medicine | A | 5/11/1998 | |
| IOMERON 300 iomeprol 61.24g/100mL injection vial | 63957 | Medicine | A | 5/11/1998 |
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
|---|---|---|---|---|---|
| No Health Canada approvals found for this drug. | |||||
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
|---|---|---|---|---|---|
| IOMERON 400 MG IODO/ML SOLUCIÓN INYECTABLE | 60811 | SOLUCIÓN INYECTABLE | Uso Hospitalario Y Centros De Diagnóstico Autorizados | Commercialized | |
| IOMERON 300 MG IODO/ML SOLUCIÓN INYECTABLE | 60809 | SOLUCIÓN INYECTABLE | Uso Hospitalario Y Centros De Diagnóstico Autorizados | Commercialized | |
| IOMERON 150 MG IODO/ML SOLUCIÓN INYECTABLE | 60806 | SOLUCIÓN INYECTABLE | Uso Hospitalario Y Centros De Diagnóstico Autorizados | Not Commercialized | |
| IOMERON 250 MG IODO/ML SOLUCIÓN INYECTABLE | 60808 | SOLUCIÓN INYECTABLE | Uso Hospitalario Y Centros De Diagnóstico Autorizados | Commercialized | |
| IOMERON 200 MG IODO/ML SOLUCIÓN INYECTABLE | 60807 | SOLUCIÓN INYECTABLE | Uso Hospitalario Y Centros De Diagnóstico Autorizados | Not Commercialized | |
| IOMERON 350 MG IODO/ML SOLUCIÓN INYECTABLE | 60810 | SOLUCIÓN INYECTABLE | Uso Hospitalario Y Centros De Diagnóstico Autorizados | Commercialized |
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Philippines FDA approvals found for this drug. | |||||
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Saudi SFDA approvals found for this drug. | |||||
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Malaysia NPRA approvals found for this drug. | |||||
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
|---|---|---|---|---|---|
| No UK EMC drug information found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.